Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
Timothy S Leung,1 Ernest H Law2 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; 2Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA Abstract: Venous thromboembolism includes deep...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-07-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/differential-benefit-risk-assessment-of-doacs-innbspthe-treatment-of-v-peer-reviewed-article-DDDT |